- Supported exchanges /
- KQ /
- 299660.KQ
Cellid Co. Ltd (299660 KQ) stock market data APIs
Cellid, Co., Ltd. develops immunotherapeutic vaccines for cancer and/or infectious diseases therapies. It is developing BVAC-C for cervical, head and neck, anal, and sex organ cancer with human papilloma virus infection; BVAC-B for stomach, breast, and ovarian cancer with HER-2/neu antigen; and BVAC-P for prostate cancer, renal cell cancer, and glioblastoma with prostate acid phosphatase (PAP) and prostate-specific membrane (PSMA) antigens. The company is also developing BVAC-M for cancers, such as melanoma with GP100/MAGE-A3 antigens; BVAC-Neo. Cellid, Co., Ltd. was founded in 2006 and is headquartered in Seoul, South Korea.
Cellid Co. Ltd Financial Data Overview
6270 | |
6400 | |
- | |
6580 | |
6090 | |
1733-17310 | |
130 839 M | |
21 103 K | |
914 M | |
-157.3805 | |
1.468 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Cellid Co. Ltd Fundamental Data is available in our Financial Data APIs
- Net Revenue 914 M
- EBITDA -8 399 299 584
- Earnings Per Share
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Cellid Co. Ltd Earnings via APIs
- Latest Release 2024-09-30
- EPS/Forecast NaN
Get Cellid Co. Ltd End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also: